Radical Cystectomy in the Treatment of Bladder Cancer

Oncological Outcome and Survival Predictors

Chen Hsun Ho, Chao Yuan Huang, Wei Chou Lin, Shih Chieh Chueh, Yeong Shiau Pu, Ming Kuen Lai, Hong Jeng Yu, Kuo How Huang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background/Purpose: To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors. Methods: Patients underwent radical cystectomy for bladder transitional cell carcinoma between March 1995 and July 2007 were evaluated. The clinical course, pathological characteristics, and clinical outcomes were described and analyzed. Results: A total of 148 patients (98 men and 50 women) with a median age of 66.7 years (range: 23.8-83.3) were included in the study. Median follow-up was 64 months. The perioperative mortality was 2.7%. The 5-year recurrence-free survival (RFS) and overall survival (OS) for all 148 patients was 61% and 53%, respectively. The 5-year RFS and OS were 68% and 62% for pT2, 65% and 59% for pT3, 11% and 9% for pT4, and 37% and 31% for nodal-positive disease, respectively. The number of positive lymph nodes was significantly associated with survival: 5-year RFS and OS were 54% and 33%, for patients with only 1-3 positive lymph nodes, whereas, all patients with ≥4 positive lymph nodes had recurrence. On multivariate analysis, age > 60 years, pT4 tumors, and lymph node involvement had a negative impact on survival. Conclusion: Radical cystectomy can be curative in a significant portion of patients with organ-confined (T2 or less) and extravesical (pT3) bladder cancer. Age > 60 years, pT4 tumors, and nodal metastases were associated with poor prognosis. Patients with limited lymph node involvement (1-3 nodes) can be cured by surgery alone, whereas a more extensive lymph node metastasis (≥ 4 nodes) eventually results in recurrence. Concomitant prostate cancer is of low grade and early stage, and is clinically insignificant.

Original languageEnglish
Pages (from-to)872-878
Number of pages7
JournalJournal of the Formosan Medical Association
Volume108
Issue number11
DOIs
Publication statusPublished - Nov 1 2009
Externally publishedYes

Fingerprint

Cystectomy
Urinary Bladder Neoplasms
Survival
Lymph Nodes
Recurrence
Therapeutics
Neoplasm Metastasis
Transitional Cell Carcinoma
Neoplasms
Prostatic Neoplasms
Urinary Bladder
Multivariate Analysis
Mortality

Keywords

  • bladder cancer
  • cystectomy
  • lymph nodes
  • neoplasm metastasis
  • survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Radical Cystectomy in the Treatment of Bladder Cancer : Oncological Outcome and Survival Predictors. / Ho, Chen Hsun; Huang, Chao Yuan; Lin, Wei Chou; Chueh, Shih Chieh; Pu, Yeong Shiau; Lai, Ming Kuen; Yu, Hong Jeng; Huang, Kuo How.

In: Journal of the Formosan Medical Association, Vol. 108, No. 11, 01.11.2009, p. 872-878.

Research output: Contribution to journalArticle

Ho, Chen Hsun ; Huang, Chao Yuan ; Lin, Wei Chou ; Chueh, Shih Chieh ; Pu, Yeong Shiau ; Lai, Ming Kuen ; Yu, Hong Jeng ; Huang, Kuo How. / Radical Cystectomy in the Treatment of Bladder Cancer : Oncological Outcome and Survival Predictors. In: Journal of the Formosan Medical Association. 2009 ; Vol. 108, No. 11. pp. 872-878.
@article{f7157dbf673a4e96a198c907867e37e6,
title = "Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors",
abstract = "Background/Purpose: To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors. Methods: Patients underwent radical cystectomy for bladder transitional cell carcinoma between March 1995 and July 2007 were evaluated. The clinical course, pathological characteristics, and clinical outcomes were described and analyzed. Results: A total of 148 patients (98 men and 50 women) with a median age of 66.7 years (range: 23.8-83.3) were included in the study. Median follow-up was 64 months. The perioperative mortality was 2.7{\%}. The 5-year recurrence-free survival (RFS) and overall survival (OS) for all 148 patients was 61{\%} and 53{\%}, respectively. The 5-year RFS and OS were 68{\%} and 62{\%} for pT2, 65{\%} and 59{\%} for pT3, 11{\%} and 9{\%} for pT4, and 37{\%} and 31{\%} for nodal-positive disease, respectively. The number of positive lymph nodes was significantly associated with survival: 5-year RFS and OS were 54{\%} and 33{\%}, for patients with only 1-3 positive lymph nodes, whereas, all patients with ≥4 positive lymph nodes had recurrence. On multivariate analysis, age > 60 years, pT4 tumors, and lymph node involvement had a negative impact on survival. Conclusion: Radical cystectomy can be curative in a significant portion of patients with organ-confined (T2 or less) and extravesical (pT3) bladder cancer. Age > 60 years, pT4 tumors, and nodal metastases were associated with poor prognosis. Patients with limited lymph node involvement (1-3 nodes) can be cured by surgery alone, whereas a more extensive lymph node metastasis (≥ 4 nodes) eventually results in recurrence. Concomitant prostate cancer is of low grade and early stage, and is clinically insignificant.",
keywords = "bladder cancer, cystectomy, lymph nodes, neoplasm metastasis, survival",
author = "Ho, {Chen Hsun} and Huang, {Chao Yuan} and Lin, {Wei Chou} and Chueh, {Shih Chieh} and Pu, {Yeong Shiau} and Lai, {Ming Kuen} and Yu, {Hong Jeng} and Huang, {Kuo How}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/S0929-6646(09)60419-8",
language = "English",
volume = "108",
pages = "872--878",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "11",

}

TY - JOUR

T1 - Radical Cystectomy in the Treatment of Bladder Cancer

T2 - Oncological Outcome and Survival Predictors

AU - Ho, Chen Hsun

AU - Huang, Chao Yuan

AU - Lin, Wei Chou

AU - Chueh, Shih Chieh

AU - Pu, Yeong Shiau

AU - Lai, Ming Kuen

AU - Yu, Hong Jeng

AU - Huang, Kuo How

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Background/Purpose: To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors. Methods: Patients underwent radical cystectomy for bladder transitional cell carcinoma between March 1995 and July 2007 were evaluated. The clinical course, pathological characteristics, and clinical outcomes were described and analyzed. Results: A total of 148 patients (98 men and 50 women) with a median age of 66.7 years (range: 23.8-83.3) were included in the study. Median follow-up was 64 months. The perioperative mortality was 2.7%. The 5-year recurrence-free survival (RFS) and overall survival (OS) for all 148 patients was 61% and 53%, respectively. The 5-year RFS and OS were 68% and 62% for pT2, 65% and 59% for pT3, 11% and 9% for pT4, and 37% and 31% for nodal-positive disease, respectively. The number of positive lymph nodes was significantly associated with survival: 5-year RFS and OS were 54% and 33%, for patients with only 1-3 positive lymph nodes, whereas, all patients with ≥4 positive lymph nodes had recurrence. On multivariate analysis, age > 60 years, pT4 tumors, and lymph node involvement had a negative impact on survival. Conclusion: Radical cystectomy can be curative in a significant portion of patients with organ-confined (T2 or less) and extravesical (pT3) bladder cancer. Age > 60 years, pT4 tumors, and nodal metastases were associated with poor prognosis. Patients with limited lymph node involvement (1-3 nodes) can be cured by surgery alone, whereas a more extensive lymph node metastasis (≥ 4 nodes) eventually results in recurrence. Concomitant prostate cancer is of low grade and early stage, and is clinically insignificant.

AB - Background/Purpose: To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors. Methods: Patients underwent radical cystectomy for bladder transitional cell carcinoma between March 1995 and July 2007 were evaluated. The clinical course, pathological characteristics, and clinical outcomes were described and analyzed. Results: A total of 148 patients (98 men and 50 women) with a median age of 66.7 years (range: 23.8-83.3) were included in the study. Median follow-up was 64 months. The perioperative mortality was 2.7%. The 5-year recurrence-free survival (RFS) and overall survival (OS) for all 148 patients was 61% and 53%, respectively. The 5-year RFS and OS were 68% and 62% for pT2, 65% and 59% for pT3, 11% and 9% for pT4, and 37% and 31% for nodal-positive disease, respectively. The number of positive lymph nodes was significantly associated with survival: 5-year RFS and OS were 54% and 33%, for patients with only 1-3 positive lymph nodes, whereas, all patients with ≥4 positive lymph nodes had recurrence. On multivariate analysis, age > 60 years, pT4 tumors, and lymph node involvement had a negative impact on survival. Conclusion: Radical cystectomy can be curative in a significant portion of patients with organ-confined (T2 or less) and extravesical (pT3) bladder cancer. Age > 60 years, pT4 tumors, and nodal metastases were associated with poor prognosis. Patients with limited lymph node involvement (1-3 nodes) can be cured by surgery alone, whereas a more extensive lymph node metastasis (≥ 4 nodes) eventually results in recurrence. Concomitant prostate cancer is of low grade and early stage, and is clinically insignificant.

KW - bladder cancer

KW - cystectomy

KW - lymph nodes

KW - neoplasm metastasis

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=71649087105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71649087105&partnerID=8YFLogxK

U2 - 10.1016/S0929-6646(09)60419-8

DO - 10.1016/S0929-6646(09)60419-8

M3 - Article

VL - 108

SP - 872

EP - 878

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 11

ER -